Palisade Bio, Inc. (PALI)
2.01
-0.04
(-1.95%)
USD |
NASDAQ |
Sep 10, 16:00
2.05
+0.04
(+1.99%)
After-Hours: 20:00
Palisade Bio Total Assets (Quarterly) : 127.32M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 127.32M |
| March 31, 2026 | 133.32M |
| December 31, 2025 | 134.34M |
| September 30, 2025 | 6.973M |
| June 30, 2025 | 6.667M |
| March 31, 2025 | 8.19M |
| December 31, 2024 | 10.88M |
| September 30, 2024 | 9.336M |
| June 30, 2024 | 12.87M |
| March 31, 2024 | 12.65M |
| December 31, 2023 | 14.05M |
| September 30, 2023 | 17.07M |
| June 30, 2023 | 18.29M |
| March 31, 2023 | 15.26M |
| December 31, 2022 | 15.76M |
| September 30, 2022 | 16.27M |
| June 30, 2022 | 7.806M |
| March 31, 2022 | 8.35M |
| December 31, 2021 | 12.51M |
| September 30, 2021 | 16.27M |
| June 30, 2021 | 14.95M |
| March 31, 2021 | 8.915M |
| December 31, 2020 | 3.019M |
| September 30, 2020 | 15.17M |
| June 30, 2020 | 17.10M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.36M |
| December 31, 2019 | 6.584M |
| September 30, 2019 | 8.944M |
| June 30, 2019 | 3.522M |
| March 31, 2019 | 5.406M |
| December 31, 2018 | 7.684M |
| September 30, 2018 | 7.721M |
| June 30, 2018 | 9.233M |
| March 31, 2018 | 11.55M |
| December 31, 2017 | 13.88M |
| September 30, 2017 | 16.19M |
| June 30, 2017 | 13.27M |
| March 31, 2017 | 18.73M |
| December 31, 2016 | 22.60M |
| September 30, 2016 | 8.451M |
| June 30, 2016 | 13.29M |
| March 31, 2016 | 10.20M |
| December 31, 2015 | 14.95M |
| September 30, 2015 | 21.14M |
| June 30, 2015 | 26.37M |
| March 31, 2015 | 30.80M |
| December 31, 2014 | 29.84M |
| September 30, 2014 | 29.44M |
| June 30, 2014 | 32.63M |
| March 31, 2014 | 35.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.567M |
| Shareholders Equity (Quarterly) | 121.75M |
| Current Ratio | 24.25 |
| Net Debt Paydown Yield | 0.00% |